Streetbeat News

Analyst Ratings

AMZN

BRK-A

BTCUSD

Charlie Munger, vice chairman of Berkshire Hathaway, shared his views on various topics in an interview with The Wall Street Journal. He discussed the challenges of making substantial acquisitions due to competitive bidding in the venture capital sector, expressed skepticism about the necessity of stock pickers, and advocated for index funds. Munger also commented on the surge in Bitcoin's value, expressing his preference for strong, sovereign-issued currencies. He disagreed with the idea of breaking up major tech companies like Amazon, appreciating their contribution to capitalism. Berkshire Hathaway's upcoming Q3 earnings are expected to benefit from high interest rates.

Portfolio Pulse from Michael Cohen

November 03, 2023 | 7:27 pm

SRC

RBC Capital analyst Brad Heffern maintains a 'Sector Perform' rating on Spirit Realty Cap (NYSE:SRC) and raises the price target from $40 to $43.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 7:27 pm

OTLK

Outlook Therapeutics (NASDAQ:OTLK) has completed Type A Meetings with the FDA, agreeing on a clinical trial design for ONS-5010, a treatment for wet AMD. The trial could allow for resubmission of the ONS-5010 BLA by end of 2024 and approval by mid-2025. HC Wainwright upgraded the stock to Buy from Neutral and increased the price target from $1 to $2. The new study is estimated to cost $35-40 million, necessitating additional financing.

Portfolio Pulse from Vandana Singh

November 03, 2023 | 7:25 pm

SIGI

RBC Capital analyst Scott Heleniak maintains a 'Sector Perform' rating on Selective Insurance Gr (NASDAQ:SIGI) and raises the price target from $105 to $108.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 7:25 pm

REGN

RBC Capital analyst Brian Abrahams has maintained a 'Sector Perform' rating on Regeneron Pharmaceuticals (NASDAQ:REGN) but lowered the price target from $847 to $837.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 7:22 pm

RDFN

RBC Capital analyst Brad Erickson has maintained a 'Sector Perform' rating on Redfin (NASDAQ:RDFN) but lowered the price target from $10 to $7.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 7:20 pm

RCM

RBC Capital analyst Sean Dodge maintains an 'Outperform' rating on R1 RCM (NASDAQ:RCM) but lowers the price target from $22 to $19.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 7:18 pm

PTVE

RBC Capital analyst Arun Viswanathan has maintained an 'Outperform' rating on Pactiv Evergreen (NASDAQ:PTVE) and raised the price target from $11 to $13.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 7:16 pm

PCRX

RBC Capital analyst Gregory Renza maintains an Outperform rating on Pacira BioSciences (NASDAQ:PCRX) but lowers the price target from $67 to $58.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 7:15 pm

CMG

A significant number of investors have taken a bearish stance on Chipotle Mexican Grill (NYSE:CMG), with 69% of detected trades showing bearish expectations. The price target range for the company over the last three months has been $1700.0 to $3000.0. Several financial institutions have maintained or downgraded their ratings on the company, with price targets ranging from $2070 to $2375. The company's stock price is currently up 0.35% at $2042.47.

Portfolio Pulse from Benzinga Insights

November 03, 2023 | 7:15 pm